Results 101 to 110 of about 82,604 (202)

Oligometastatic Melanoma Treated by Metastasectomy in Combination with Immune Checkpoint and BRAF Inhibitors: A Case Series. [PDF]

Am J Case Rep, 2023
Palmer JP, Suriawinata AA, Yan S, Kerr DA, Afzal MZ, Shirai K.   +5 more
europepmc   +1 more source

MEK inhibitors cobimetinib and trametinib, regressed a gemcitabine-resistant pancreatic-cancer patient-derived orthotopic xenograft (PDOX). [PDF]

, 2017
A pancreatic ductal adenocarcinoma (PDAC), obtained from a patient, was grown orthotopically in the pancreatic tail of nude mice to establish a patient-derived orthotopic (PDOX) model.
Bouvet, Michael, Clary, Bryan M, Delong, Jonathan C, Hoffman, Robert M, Hwang, Ho Kyoung, Igarashi, Kentaro, Kawaguchi, Kei, Kiyuna, Tasuku, Lwin, Thinzar M, Murakami, Takashi, Unno, Michiaki   +10 more
core  

Kisspeptin-mediated improvement of sensitivity to BRAF inhibitors in vemurafenib-resistant melanoma cells. [PDF]

Front Oncol, 2023
Guzzetti C, Corno C, Vergani E, Mirra L, Ciusani E, Rodolfo M, Perego P, Beretta GL.   +7 more
europepmc   +1 more source

BRAF Inhibitor [PDF]

, 2020
openaire   +1 more source

BRAF Inhibitors in Non-Small Cell Lung Cancer. [PDF]

Cancers (Basel), 2022
Sforza V, Palumbo G, Cascetta P, Carillio G, Manzo A, Montanino A, Sandomenico C, Costanzo R, Esposito G, Laudato F, Damiano S, Forte CA, Frosini G, Farese S, Piccirillo MC, Pascarella G, Normanno N, Morabito A.   +17 more
europepmc   +1 more source

Tumor-Type Agnostic, Targeted Therapies: BRAF Inhibitors Join the Group. [PDF]

Acta Med Acad, 2022
Vranic S, Basu GD, Hall DW, Gatalica Z.
europepmc   +1 more source

BRAF inhibitors in BRAF V600E-mutated ameloblastoma: systematic review of rare cases in the literature. [PDF]

Med Oncol, 2023
Ebeling M, Scheurer M, Sakkas A, Pietzka S, Schramm A, Wilde F.   +5 more
europepmc   +1 more source

High frequency of BRAF mutations and concomitant KRAS mutations in Taiwanese ovarian clear cell carcinoma

Taiwanese Journal of Obstetrics & Gynecology
Objectives: Given encouraging clinical evidence of BRAF inhibitors for melanoma, etc., we investigated BRAF mutation status in ovarian clear cell carcinoma (OCCC) from Taiwanese women and assessed the association of BRAF mutation with KRAS mutation ...
Huang-Pin Shen, Ming-Yung Lee, Wan-Ru Chao, Yi-Ju Lee, Gwo-Tarng Sheu, Pi-Chieh Wang, Chi-Kuan Chen, Chih-Ping Han   +7 more
doaj   +1 more source

BRAF inhibitors in BRAFV600E-mutated pediatric high-grade gliomas: Upfront or at recurrence? [PDF]

Neuro Oncol, 2022
Nobre L, Bouffet E.
europepmc   +1 more source

BRAF Inhibitor LUT014 [PDF]

, 2020
openaire   +1 more source